139 related articles for article (PubMed ID: 38359384)
1. Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma.
Berg SA; Galsky MD
J Clin Oncol; 2024 May; 42(13):1459-1461. PubMed ID: 38359384
[No Abstract] [Full Text] [Related]
2. UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.
Grande P; Rouprêt M
Nat Rev Urol; 2018 Feb; 15(2):73-74. PubMed ID: 29182602
[No Abstract] [Full Text] [Related]
3. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
[TBL] [Abstract][Full Text] [Related]
5. Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma: A protocol for systematic review and meta analysis.
Li K; Xie W; Gao L; Huang G; Zhou J; Mei B; Chen J
Medicine (Baltimore); 2020 May; 99(18):e20184. PubMed ID: 32358407
[TBL] [Abstract][Full Text] [Related]
6. [PPA (cis-platinum), peplomycin and adriamycin) combination chemotherapy in transitional cell carcinoma of the urothelial tract--pilot study].
Ono Y; Ohshima S; Fujita T; Naide Y; Suzuki K; Asoh Y; Fukushima M; Ohta K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):28-33. PubMed ID: 2422307
[No Abstract] [Full Text] [Related]
7. Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.
Song YS; Cho JS; Cho KS; Doo SH; Chung BH; Kim SJ; Yang WJ; Song KH; Kim CI; Hong SJ
Urol Int; 2010; 85(1):47-51. PubMed ID: 20234122
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
Vassilakopoulou M; de la Motte Rouge T; Colin P; Ouzzane A; Khayat D; Dimopoulos MA; Papadimitriou CA; Bamias A; Pignot G; Nouhaud FX; Hurel S; Guy L; Bigot P; Roumiguié M; Rouprêt M;
Cancer; 2011 Dec; 117(24):5500-8. PubMed ID: 21638278
[TBL] [Abstract][Full Text] [Related]
9. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
10. Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.
Afferi L; Moschini M; Mattei A; Montorsi F; Briganti A; Cathelineau X; Sanchez-Salas R
Eur Urol; 2020 Aug; 78(2):289-290. PubMed ID: 32359702
[No Abstract] [Full Text] [Related]
11. Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
Kondo T
Int J Urol; 2024 May; 31(5):560-561. PubMed ID: 38424666
[No Abstract] [Full Text] [Related]
12. Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
Ishihara H; Takagi T
Int J Urol; 2024 May; 31(5):559-560. PubMed ID: 38366784
[No Abstract] [Full Text] [Related]
13. Advancements in the clinical management of upper tract urothelial carcinoma.
Taylor J; Meng X; Ghandour R; Margulis V
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1051-1060. PubMed ID: 31770492
[No Abstract] [Full Text] [Related]
14. BCG for upper-tract transitional-cell carcinoma: is it safe in patients with renal compromise?
Binsaleh S; Sircar K; Elhilali M; Anidjar M
J Endourol; 2006 Dec; 20(12):1068-71. PubMed ID: 17206904
[TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinoma of the upper uroepithelial tract.
Michaelson MD; Kaufman DS; Oh WK
Clin Adv Hematol Oncol; 2003 Feb; 1(2):102-4; discussion 105. PubMed ID: 16224387
[No Abstract] [Full Text] [Related]
16. Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.
Birtle AJ; Lewis R; Johnson M; Hall E;
BJU Int; 2012 Oct; 110(7):919-21. PubMed ID: 22882350
[No Abstract] [Full Text] [Related]
17. Invited commentary.
Spaggiari L; Casiraghi M
Ann Thorac Surg; 2011 Aug; 92(2):453-4. PubMed ID: 21801906
[No Abstract] [Full Text] [Related]
18. [High response rates for erdafitinib in patients with FGFR-mutated urothelial carcinoma following failure of platinum-based chemotherapy].
Grülllich C
Urologe A; 2020 Apr; 59(4):478-479. PubMed ID: 32103289
[No Abstract] [Full Text] [Related]
19. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
